Loading
Logo
Discover More

Product Details

Retatrutide10
<
>
Retatrutide10
Retatrutide10
Retatrutide10

// Quality First, Safety Guaranteed.

Retatrutide10

Peptides

Retatrutide10

Basic Info.

Retatrutide10 is an experimental drug developed by Eli Lilly and Company in the United States for the treatment of obesity. It is a triple glucagon hormone receptor agonist.

In a phase II clinical trial, the drug has been proved to reduce the average weight of non diabetes but obese or pre obese (overweight) adults by more than 17.5%


Areas of Expertise

  • Check icon Leading-Edge Manufacturing Capabilityg
  • Check icon Advanced R&D and State-of-the-Art Facilities
  • Check icon Versatile and Scalable Packaging Solutions
  • Check icon Certified Quality & International Compliance
Previous image
< Previous
LL37
Next >
melatonin
Next image

Leave a message

Happy to answer all your questions.